Surgery Partners, Inc.
SGRY
$17.07
$0.010.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.14% | 12.05% | 13.54% | 13.52% | 9.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.14% | 12.05% | 13.54% | 13.52% | 9.96% |
| Cost of Revenue | 9.74% | 12.45% | 13.88% | 13.02% | 9.77% |
| Gross Profit | 11.45% | 10.77% | 12.47% | 15.15% | 10.56% |
| SG&A Expenses | 5.58% | 4.65% | 15.89% | 14.72% | -3.96% |
| Depreciation & Amortization | 0.13% | 25.06% | 31.41% | 29.21% | 28.47% |
| Other Operating Expenses | 12.67% | 2.86% | -106.90% | -166.67% | -20.97% |
| Total Operating Expenses | 9.10% | 12.78% | 14.52% | 13.44% | 9.89% |
| Operating Income | 16.06% | 8.03% | 8.28% | 14.01% | 10.34% |
| Income Before Tax | 18.23% | -12.81% | -28.03% | 8.96% | 8.74% |
| Income Tax Expenses | 532.32% | 575.00% | 2,184.21% | 44,966.67% | 450.00% |
| Earnings from Continuing Operations | -77.98% | -96.59% | -107.64% | -90.76% | -5.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -17.01% | -13.44% | -14.89% | -22.69% | -13.82% |
| Net Income | -182.84% | -433.73% | -32,333.33% | -1,312.61% | -76.68% |
| EBIT | 16.06% | 8.03% | 8.28% | 14.01% | 10.34% |
| EBITDA | 12.06% | 11.83% | 13.20% | 17.38% | 14.39% |
| EPS Basic | -182.14% | -432.39% | -31,357.14% | -1,293.51% | -51.43% |
| Normalized Basic EPS | -4,358.06% | -463.96% | -316.33% | 94.94% | 103.23% |
| EPS Diluted | -182.04% | -428.20% | -76,790.00% | -1,261.02% | -49.95% |
| Normalized Diluted EPS | -4,358.06% | -463.96% | -312.00% | 83.33% | 103.25% |
| Average Basic Shares Outstanding | 0.58% | 0.46% | 0.38% | 0.41% | 5.33% |
| Average Diluted Shares Outstanding | 0.58% | 0.46% | 0.05% | 0.08% | 4.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |